Revolution Medicines RVMD
NASDAQ RVMD
$192.28 +14.63 (+8.24%)
At close: Nov 6, 2026 · 4:00 PM EST

Revolution Medicines (RVMD) Net Preferred Shares Issued and Repurchased (2019)

Updated

Revolution Medicines (RVMD) recorded Net Preferred Shares Issued and Repurchased of -$5,000 in Q4 2019.

Analysis

Revolution Medicines (RVMD) Net Preferred Shares Issued and Repurchased (2019) Analysis & Trends

For FY2019, Revolution Medicines reported Net Preferred Shares Issued and Repurchased of $100.03 million, up 65.2% from FY2018.

  • Across earlier years, Net Preferred Shares Issued and Repurchased came in at $60.56 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Revolution Medicines 41.45 Bn 29.93 Bn 197.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -5,000.00
Sep 30, 2019 9.86 Mn
API Access

Revolution Medicines Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=RVMD&period=max&api_key=YOUR_API_KEY